New cancer clinical trial: A Trial of Tisotumab Vedotin in Cervical Cancer

Published on: February 19, 2018 at 12:00PM
Condition:   Cervical Cancer
Intervention:   Drug: tisotumab vedotin
Sponsors:   Genmab;   Seattle Genetics, Inc.;   European Network of Gynaecological Oncological Trial Groups (ENGOT);   Belgian Gynaecological Oncology Group;   Gynecologic Oncology Group
Not yet recruiting
http://ift.tt/2FgsboK